CHAOJU EYE CARE Reports Annual Results with Net Profit Attributable to Owners of RMB 1.83 Billion, Down 5.96% Year-on-Year

Stock News
Mar 31

CHAOJU EYE CARE (02219) announced its annual results for the period ending December 31, 2025. The Group recorded revenue of RMB 13.6 billion, a decrease of 3.21% compared to the previous year. Profit attributable to owners of the parent company was RMB 1.83 billion, representing a decline of 5.96% year-on-year. Earnings per share were RMB 0.26. The Board has proposed a final dividend of HK$0.2423 per share.

The Group's revenue from consumer ophthalmic services decreased by 2.4% to RMB 6.9 billion for the year ending December 31, 2025, down from RMB 7.06 billion for the year ending December 31, 2024. This was primarily attributed to pricing adjustments implemented in response to intensified market competition, particularly in refractive surgery services.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10